Axogen, Inc. (AXGN)
29.78
-0.61
(-2.01%)
USD |
NASDAQ |
Dec 15, 16:00
29.78
0.00 (0.00%)
After-Hours: 20:00
Axogen Research and Development Expense (Quarterly): 7.565M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Phibro Animal Health Corp. | -- |
| IRIDEX Corp. | 0.972M |
| Stereotaxis, Inc. | 2.546M |
| Electromed, Inc. | 0.241M |
| Myomo, Inc. | 1.528M |